Explore more publications!

European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on December 7, 2025

GoHighLevel SaaS Mode: New Guide Uncovers the Most Profitable Agency Model of 2026
Innovation Driven Water Sustainability Conference Returns With Record Global Participation, Technologies, and Awards
Innovation Driven Water Sustainability Conference Returns With Record Global Participation, Technologies, and Awards
SIAD Holding Concludes Jeddah Hajj Conference Participation, Inks Major Hospitality Deal
Top 50 New Year Celebration Cities Around the Globe Revealed by Travel and Tour World for 2025-26
EAA Foundation Calls For ‘Education as Justice’ To Protect Learning in Crises at Doha Forum
MANOR OF DARKNESS: HIGH STAKES & THRILLER DRIVEN
PROPSTORE ACHIEVES $10.2 MILLION IN DAY ONE RESULTS AS LONDON ENTERTAINMENT MEMORABILIA AUCTION OPENS STRONGLY
Disruptive Futures Institute Names Metaruptions 2026 Word of the Year & Launches Roger Spitz’s Visionary Keynote Series
Selling Online Challenge With Russell Brunson Announces December 9–11, 2025 Live Virtual Training
100 pilotos compiten por un jet privado
100 pilotos competem por um jato privado
Osmer Martínez Unveils 'Powerful Anticommunist Manifesto: No More Darkness for Humanity'
Payment as a Service Market Expected to Reach $53.6 Billion by 2031 | 21.4% CAGR Outlook
Smart Building Market Poised to Surpass $247.17 Billion by 2032 | Growing at 12.3% CAGR
USD 9.92 Billion Growth Expected in Europe Commercial Refrigeration Market | UK to  Grow at 3.3% CAGR | AMR
Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025
SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025
ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025
Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions